The efficacy and safety of benfluorex within 16 week treatment for type 2 diabetes mellitus is comparable to those of Metfomin treatment with mild adverse side effects. In addition,we also found that benfluorex can improve insulin resistance and lipid profile.
结论苯氟雷司和二甲双胍在为期16周的临床疗效研究中,有相似的降糖作用,改善胰岛素抵抗及降血脂效果更显著,且不良反应轻微。
参考来源 - 苯氟雷司治疗2型糖尿病有效性和安全性研究·2,447,543篇论文数据,部分数据来源于NoteExpress
应用推荐